Shattuck Labs

IPO

Shattuck Labs is a biotech company in Austin, United States, founded in 2016. It has raised $221.0M across 2 rounds, most recently a $103.0M Corporate Round in August 2025.

Advancing DR3-targeting therapies for IBD and beyond.

Headquarters
Austin, Texas
Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$221.0M
Last Round
$103.0M Corporate RoundAug 2025
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

Shattuck Labs (NASDAQ: STTK) is a clinical-stage biotechnology company developing novel DR3-targeting biologic therapies for inflammatory and immune-mediated diseases. Its lead program, SL-325, is a potentially first-in-class DR3 blocking antibody in Phase 1 development for inflammatory bowel disease. Founded in 2016 and headquartered in Austin, Texas.

Summary

It lists 51–200 employees. It has raised $221.0M in total across 2 rounds, most recently a $103.0M Corporate Round in Aug 2025. Investors include Redmile Group, OrbiMed and Coastlands Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundAug 2025
$103.0M

Sign up to see all 3 events

Funding: Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Shattuck Labs on Indexed.vc
<a href="https://indexed.vc/companies/shattuck-labs"><img src="https://indexed.vc/api/badge/company/shattuck-labs" alt="Shattuck Labs on Indexed.vc" width="260" height="76" /></a>